Zurich & Further Offer New Critical Care Solution
Product hailed as "A significant advancement in international group protection benefits"

Zurich and Further Group in May 2025 announced they would offer a new employee benefit – called Critical Care – designed to help those needing treatment for serious illnesses. Critical Care can provide life-changing well-being benefits for employees who have cancer, heart or neurological conditions, are in need of organ transplants, or require specialist treatment abroad at leading hospitals. It can be added to any Zurich International Group Life or Group Income Protection Policy, allowing employers to meet the changing needs of their workforce.

Head of Distribution & CRM,
Zurich International Corporate Solutions
Andrew Wood, Head of Distribution & CRM, Zurich International Corporate Solutions, commented: “Critical Care has been carefully designed to offer quicker access to diagnoses and treatment, which in turn increases the chances of positive outcomes, leading to a better quality of life. Over the past decade UK NHS figures show that serious illnesses have surged with heart disease increasing by 50% and around half of the population facing a cancer diagnosis in their lifetime. Similar trends are being seen in the other regions and countries where Critical Care will be available. This is driving a need for employers to provide even better protection benefits for their current and future employees. Critical Care empowers employees by offering a comprehensive suite of services for those diagnosed with serious illnesses, ensuring swift access to the best available treatments for their needs.
Nigel Simpson, Head of International Markets, Zurich International, said: “Critical Care marks a significant advancement in employee group protection benefits. As a solution which meets the modern-day needs of employers who want to go the extra mile to support employees on their wellbeing journey, we also see it as a unique offering which sets Zurich apart in the employee benefits market. We are immensely proud of this new benefit and to offer it in partnership with Further Group, which is a leading business in this field.”

Head of International Markets,
Zurich International
From an employer’s point of view, Critical Care provides their workforce with more choice and control over their healthcare decisions. It gives fast access to leading medical experts for initial consultations, second medical opinions and treatment options that might not be available where the employee lives. In a scenario where an employee has been diagnosed with advanced stage cancer and fast access to the best possible treatment is vital, Critical Care gives them the option to choose the latest cancer medicines and clinical trials.
In more detail, Critical Care consists of the following services:
- Second Medical Opinion
- Precision Cancer Medicine – Covered employees who receive a qualifying cancer diagnosis get fast access to a personalized treatment plan based on their specific type and cause of cancer, using the latest tumor profiling technology. If the cancer has a hereditary or genetic component, siblings and children are also eligible for testing and counselling.
- Cancer Clinical Trial Support – If covered employees with a cancer diagnosis decide it is right for them, Critical Care can help them to access one of the hundreds of thousands of clinical trials taking place worldwide. This may give them access to new or alternative treatments, drugs and therapies that may not yet be available to everyone. Critical Care covers the cost of travel and accommodation during this time, as well as a daily allowance for customers and their travel companions.
- Global Treatment Plus+ Global Treatment Plus+ offers covered employees the option to be treated at some of the world’s leading hospitals and medical facilities, potentially giving access to treatments that might not be offered locally. Critical Care covers the cost of treatment, travel and accommodation as well as a daily allowance for customers and their travel companions, as well as in country follow-up care and continuing medication expenses.
Customers will have flexibility when it comes to using any of the services Critical Care offers. They can choose which services to use and when, with the option to combine them with public or private healthcare, offering them greater control over their healthcare decisions. In addition, customers who access the service will be guided through the entire process by a dedicated, clinically trained case manager.
Critical Care has been made possible by Zurich’s partnership with Further Group which specializes in the design and development of health insurance products and services. It operates in over 30 countries and has over 3.5 million customers worldwide.

Frank Ahedo, CEO of Further, said: “At Further, we are incredibly proud to collaborate with Zurich to offer ‘Critical Care’. This innovative benefit provides employees with comprehensive support and access to cutting-edge treatments globally during critical health moments. Our expertise in specialist health solutions, combined with Zurich’s strength, means we can provide peace of mind and vital options to individuals when they need it most.”
No Comment